Literature DB >> 9680134

Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.

R M Powell1, V Schmitt, T Ward, I Goodfellow, D J Evans, J W Almond.   

Abstract

Several echoviruses (EVs) have previously been shown to use decay accelerating factor (DAF) as a cellular receptor. Since DAF is expressed on erythrocytes, EVs that use this receptor cause haemagglutination. Here we show that all EVs that haemagglutinate do so via attachment to DAF and that this interaction can be inhibited by a monoclonal antibody (MAb) specific for DAF domain SCR3. Although the viruses haemagglutinate via DAF some can bind to rhabdomyosarcoma cells from which DAF has been removed and infect in the presence of a MAb against DAF. This suggests that some EVs have the capacity to interact with more than one cellular receptor.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9680134     DOI： 10.1099/0022-1317-79-7-1707

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  26 in total

1.  Engineered BGMK cells for sensitive and rapid detection of enteroviruses.

Authors:  Yung T Huang; Paul Yam; Huimin Yan; Yan Sun
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

Authors:  Yongning He; Feng Lin; Paul R Chipman; Carol M Bator; Timothy S Baker; Menachem Shoham; Richard J Kuhn; M Edward Medof; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

3.  Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells.

Authors:  Joseph T C Shieh; Jeffrey M Bergelson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Authors:  Amanda D Stuart; Thomas A McKee; Pamela A Williams; Chris Harley; Shuo Shen; David I Stuart; T David K Brown; Susan M Lea
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells.

Authors:  Nitesh Mistry; Hirotoshi Inoue; Fariba Jamshidi; Rickard J Storm; M Steven Oberste; Niklas Arnberg
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

8.  A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication.

Authors:  S S Bradrick; E A Lieben; B M Carden; J R Romero
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Early Entry Events in Echovirus 30 Infection.

Authors:  Helena Vandesande; Mira Laajala; Tino Kantoluoto; Visa Ruokolainen; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

10.  A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR.

Authors:  Nina Jonsson; Maria Gullberg; Stina Israelsson; A Michael Lindberg
Journal:  Virol J       Date:  2009-12-07       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.